ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Buspirone Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Published Date: December 2022
|
Report Code: QYRE-Auto-0W8602
Home | Market Reports | Health| Mental Health| Anxiety & Stress
Global Buspirone Market Insights Forecast to 2028
BUY CHAPTERS

Global Buspirone Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Code: QYRE-Auto-0W8602
Report
December 2022
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bristol–Myers Squibb
Apotex
Dr. Reddy’s Laboratories
Laboratoires Servier
TEVA
AMAG Pharmaceuticals
Mylan NV
Novartis
Watson Laboratories
Hikma
WOCKHARDT
Cadila Healthcare
Orion Corporation
Buspirone, sold under the brand name Buspar among others, is a medication primarily used to treat anxiety disorders, particularly generalized anxiety disorder. Benefits support its short term use. It has not been found to be effective in treating psychosis. It is taken by mouth, and it may take up to four weeks for an effect.
Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Buspirone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Buspirone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Buspirone is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Buspirone include Bristol Myers Squibb, Apotex, Dr. Reddy's Laboratories, Laboratoires Servier, Teva, AMAG Pharmaceuticals, Mylan, Novartis and Watson Laboratories, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Buspirone manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Buspirone market. Further, it explains the major drivers and regional dynamics of the global Buspirone market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Bristol Myers Squibb
Apotex
Dr. Reddy's Laboratories
Laboratoires Servier
Teva
AMAG Pharmaceuticals
Mylan
Novartis
Watson Laboratories
Hikma
Wockhardt
Cadila Healthcare
Orion Corporation
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Buspirone Segment by Type

5mg
10mg
15mg
30mg

Buspirone Segment by Application

Hospital
Drug Store
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Buspirone market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Buspirone, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Buspirone, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Buspirone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Buspirone sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Buspirone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Buspirone sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bristol Myers Squibb, Apotex, Dr. Reddy's Laboratories, Laboratoires Servier, Teva, AMAG Pharmaceuticals, Mylan, Novartis and Watson Laboratories, etc.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Buspirone Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 5mg
1.2.3 10mg
1.2.4 15mg
1.2.5 30mg
1.3 Market Segment by Application
1.3.1 Global Buspirone Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Buspirone Market Size (2017-2028)
2.1.1 Global Buspirone Revenue (2017-2028)
2.1.2 Global Buspirone Sales (2017-2028)
2.2 Global Buspirone Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Buspirone Sales by Regions (2017-2022)
2.2.2 Global Buspirone Revenue by Regions (2017-2022)
2.3 Global Buspirone Market Size Forecast by Region
2.3.1 Global Buspirone Sales Forecast by Region (2023-2028)
2.3.2 Global Buspirone Revenue Forecast by Region (2023-2028)
2.4 Global Top Buspirone Regions (Countries) Ranking by Market Size
2.5 Buspirone Market Dynamics
2.5.1 Buspirone Market Trends
2.5.2 Buspirone Market Drivers
2.5.3 Buspirone Market Challenges
2.5.4 Buspirone Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Buspirone Manufacturers by Sales (2017-2022)
3.1.1 Global Buspirone Sales by Manufacturers (2017-2022)
3.1.2 Global Buspirone Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Buspirone Sales in 2021
3.2 Global Top Manufacturers Buspirone by Revenue
3.2.1 Global Buspirone Revenue by Manufacturers (2017-2022)
3.2.2 Top Buspirone Manufacturers Covered: Ranking by Revenue
3.2.3 Global Buspirone Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Buspirone Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Buspirone as of 2021)
3.4 Global Buspirone Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Buspirone Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Buspirone Market
3.7 Key Manufacturers Buspirone Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Buspirone Market Size by Type
4.1 Global Buspirone Historic Market Review by Type (2017-2022)
4.1.1 Global Buspirone Sales Market Share by Type (2017-2022)
4.1.2 Global Buspirone Revenue Market Share by Type (2017-2022)
4.1.3 Buspirone Price by Type (2017-2022)
4.2 Global Buspirone Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Buspirone Sales Forecast by Type (2023-2028)
4.2.2 Global Buspirone Revenue Forecast by Type (2023-2028)
4.2.3 Buspirone Price Forecast by Type (2023-2028)
5 Global Buspirone Market Size by Application
5.1 Global Buspirone Historic Market Review by Application (2017-2022)
5.1.1 Global Buspirone Sales Market Share by Application (2017-2022)
5.1.2 Global Buspirone Revenue Market Share by Application (2017-2022)
5.1.3 Buspirone Price by Application (2017-2022)
5.2 Global Buspirone Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Buspirone Sales Forecast by Application (2023-2028)
5.2.2 Global Buspirone Revenue Forecast by Application (2023-2028)
5.2.3 Buspirone Price Forecast by Application (2023-2028)
6 North America
6.1 North America Buspirone Sales Breakdown by Company
6.1.1 North America Buspirone Sales by Company (2017-2022)
6.1.2 North America Buspirone Revenue by Company (2017-2022)
6.2 North America Buspirone Market Size by Type
6.2.1 North America Buspirone Sales by Type (2017-2028)
6.2.2 North America Buspirone Revenue by Type (2017-2028)
6.3 North America Buspirone Market Size by Application
6.3.1 North America Buspirone Sales by Application (2017-2028)
6.3.2 North America Buspirone Revenue by Application (2017-2028)
6.4 North America Buspirone Market Size by Country
6.4.1 North America Buspirone Sales by Country (2017-2028)
6.4.2 North America Buspirone Revenue by Country (2017-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Buspirone Sales Breakdown by Company
7.1.1 Europe Buspirone Sales by Company (2017-2022)
7.1.2 Europe Buspirone Revenue by Company (2017-2022)
7.2 Europe Buspirone Market Size by Type
7.2.1 Europe Buspirone Sales by Type (2017-2028)
7.2.2 Europe Buspirone Revenue by Type (2017-2028)
7.3 Europe Buspirone Market Size by Application
7.3.1 Europe Buspirone Sales by Application (2017-2028)
7.3.2 Europe Buspirone Revenue by Application (2017-2028)
7.4 Europe Buspirone Market Size by Country
7.4.1 Europe Buspirone Sales by Country (2017-2028)
7.4.2 Europe Buspirone Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Buspirone Sales Breakdown by Company
8.1.1 Asia Pacific Buspirone Sales by Company (2017-2022)
8.1.2 Asia Pacific Buspirone Revenue by Company (2017-2022)
8.2 Asia Pacific Buspirone Market Size by Type
8.2.1 Asia Pacific Buspirone Sales by Type (2017-2028)
8.2.2 Asia Pacific Buspirone Revenue by Type (2017-2028)
8.3 Asia Pacific Buspirone Market Size by Application
8.3.1 Asia Pacific Buspirone Sales by Application (2017-2028)
8.3.2 Asia Pacific Buspirone Revenue by Application (2017-2028)
8.4 Asia Pacific Buspirone Market Size by Region
8.4.1 Asia Pacific Buspirone Sales by Region
8.4.2 Asia Pacific Buspirone Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Buspirone Sales Breakdown by Company
9.1.1 Latin America Buspirone Sales by Company (2017-2022)
9.1.2 Latin America Buspirone Revenue by Company (2017-2022)
9.2 Latin America Buspirone Market Size by Type
9.2.1 Latin America Buspirone Sales by Type (2017-2028)
9.2.2 Latin America Buspirone Revenue by Type (2017-2028)
9.3 Latin America Buspirone Market Size by Application
9.3.1 Latin America Buspirone Sales by Application (2017-2028)
9.3.2 Latin America Buspirone Revenue by Application (2017-2028)
9.4 Latin America Buspirone Market Size by Country
9.4.1 Latin America Buspirone Sales by Country (2017-2028)
9.4.2 Latin America Buspirone Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Buspirone Sales Breakdown by Company
10.1.1 Middle East and Africa Buspirone Sales by Company (2017-2022)
10.1.2 Middle East and Africa Buspirone Revenue by Company (2017-2022)
10.2 Middle East and Africa Buspirone Market Size by Type
10.2.1 Middle East and Africa Buspirone Sales by Type (2017-2028)
10.2.2 Middle East and Africa Buspirone Revenue by Type (2017-2028)
10.3 Middle East and Africa Buspirone Market Size by Application
10.3.1 Middle East and Africa Buspirone Sales by Application (2017-2028)
10.3.2 Middle East and Africa Buspirone Revenue by Application (2017-2028)
10.4 Middle East and Africa Buspirone Market Size by Country
10.4.1 Middle East and Africa Buspirone Sales by Country (2017-2028)
10.4.2 Middle East and Africa Buspirone Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Bristol Myers Squibb
11.1.1 Bristol Myers Squibb Corporation Information
11.1.2 Bristol Myers Squibb Overview
11.1.3 Bristol Myers Squibb Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Bristol Myers Squibb Buspirone Products and Services
11.1.5 Bristol Myers Squibb Buspirone SWOT Analysis
11.1.6 Bristol Myers Squibb Recent Developments
11.2 Apotex
11.2.1 Apotex Corporation Information
11.2.2 Apotex Overview
11.2.3 Apotex Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Apotex Buspirone Products and Services
11.2.5 Apotex Buspirone SWOT Analysis
11.2.6 Apotex Recent Developments
11.3 Dr. Reddy's Laboratories
11.3.1 Dr. Reddy's Laboratories Corporation Information
11.3.2 Dr. Reddy's Laboratories Overview
11.3.3 Dr. Reddy's Laboratories Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Dr. Reddy's Laboratories Buspirone Products and Services
11.3.5 Dr. Reddy's Laboratories Buspirone SWOT Analysis
11.3.6 Dr. Reddy's Laboratories Recent Developments
11.4 Laboratoires Servier
11.4.1 Laboratoires Servier Corporation Information
11.4.2 Laboratoires Servier Overview
11.4.3 Laboratoires Servier Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Laboratoires Servier Buspirone Products and Services
11.4.5 Laboratoires Servier Buspirone SWOT Analysis
11.4.6 Laboratoires Servier Recent Developments
11.5 Teva
11.5.1 Teva Corporation Information
11.5.2 Teva Overview
11.5.3 Teva Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Teva Buspirone Products and Services
11.5.5 Teva Buspirone SWOT Analysis
11.5.6 Teva Recent Developments
11.6 AMAG Pharmaceuticals
11.6.1 AMAG Pharmaceuticals Corporation Information
11.6.2 AMAG Pharmaceuticals Overview
11.6.3 AMAG Pharmaceuticals Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 AMAG Pharmaceuticals Buspirone Products and Services
11.6.5 AMAG Pharmaceuticals Buspirone SWOT Analysis
11.6.6 AMAG Pharmaceuticals Recent Developments
11.7 Mylan
11.7.1 Mylan Corporation Information
11.7.2 Mylan Overview
11.7.3 Mylan Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Mylan Buspirone Products and Services
11.7.5 Mylan Buspirone SWOT Analysis
11.7.6 Mylan Recent Developments
11.8 Novartis
11.8.1 Novartis Corporation Information
11.8.2 Novartis Overview
11.8.3 Novartis Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Novartis Buspirone Products and Services
11.8.5 Novartis Buspirone SWOT Analysis
11.8.6 Novartis Recent Developments
11.9 Watson Laboratories
11.9.1 Watson Laboratories Corporation Information
11.9.2 Watson Laboratories Overview
11.9.3 Watson Laboratories Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Watson Laboratories Buspirone Products and Services
11.9.5 Watson Laboratories Buspirone SWOT Analysis
11.9.6 Watson Laboratories Recent Developments
11.10 Hikma
11.10.1 Hikma Corporation Information
11.10.2 Hikma Overview
11.10.3 Hikma Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Hikma Buspirone Products and Services
11.10.5 Hikma Buspirone SWOT Analysis
11.10.6 Hikma Recent Developments
11.11 Wockhardt
11.11.1 Wockhardt Corporation Information
11.11.2 Wockhardt Overview
11.11.3 Wockhardt Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Wockhardt Buspirone Products and Services
11.11.5 Wockhardt Recent Developments
11.12 Cadila Healthcare
11.12.1 Cadila Healthcare Corporation Information
11.12.2 Cadila Healthcare Overview
11.12.3 Cadila Healthcare Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 Cadila Healthcare Buspirone Products and Services
11.12.5 Cadila Healthcare Recent Developments
11.13 Orion Corporation
11.13.1 Orion Corporation Corporation Information
11.13.2 Orion Corporation Overview
11.13.3 Orion Corporation Buspirone Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Orion Corporation Buspirone Products and Services
11.13.5 Orion Corporation Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Buspirone Value Chain Analysis
12.2 Buspirone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Buspirone Production Mode & Process
12.4 Buspirone Sales and Marketing
12.4.1 Buspirone Sales Channels
12.4.2 Buspirone Distributors
12.5 Buspirone Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Bristol–Myers Squibb
Apotex
Dr. Reddy’s Laboratories
Laboratoires Servier
TEVA
AMAG Pharmaceuticals
Mylan NV
Novartis
Watson Laboratories
Hikma
WOCKHARDT
Cadila Healthcare
Orion Corporation
List of Tables
    Table 1. Global Buspirone Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of 5mg
    Table 3. Major Manufacturers of 10mg
    Table 4. Major Manufacturers of 15mg
    Table 5. Major Manufacturers of 30mg
    Table 6. Global Buspirone Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Buspirone Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
    Table 8. Global Buspirone Sales by Region (2017-2022) & (K Units)
    Table 9. Global Buspirone Sales Market Share by Region (2017-2022)
    Table 10. Global Buspirone Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Buspirone Revenue Market Share by Region (2017-2022)
    Table 12. Global Buspirone Sales Forecast by Region (2023-2028) & (K Units)
    Table 13. Global Buspirone Sales Market Share Forecast by Region (2023-2028)
    Table 14. Global Buspirone Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 15. Global Buspirone Revenue Market Share Forecast by Region (2023-2028)
    Table 16. Top Buspirone Regions (Countries) Ranking by Market Size (US$ Million) in 2021
    Table 17. Buspirone Market Trends
    Table 18. Buspirone Market Drivers
    Table 19. Buspirone Market Challenges
    Table 20. Buspirone Market Restraints
    Table 21. Global Buspirone Sales by Manufacturers (2017-2022) & (K Units)
    Table 22. Global Buspirone Sales Share by Manufacturers (2017-2022)
    Table 23. Global Buspirone Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 24. Ranking of Global Top Buspirone Manufacturers by Revenue (US$ Million) in 2021
    Table 25. Buspirone Revenue Share by Manufacturers (2017-2022)
    Table 26. Global Buspirone Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Buspirone as of 2021)
    Table 28. Key Manufacturers Buspirone Average Selling Price (ASP) & (2017-2022) & (US$/Unit)
    Table 29. Key Manufacturers Buspirone Plants/Factories Distribution
    Table 30. Key Manufacturers Buspirone Area Served
    Table 31. Date of Key Manufacturers Enter into Buspirone Market
    Table 32. Key Manufacturers Buspirone Product Type
    Table 33. Mergers & Acquisitions, Expansion Plans
    Table 34. Global Buspirone Sales (K Units) by Type (2017-2022)
    Table 35. Global Buspirone Sales Share by Type (2017-2022)
    Table 36. Global Buspirone Revenue (US$ Million) Market Share by Type (2017-2022)
    Table 37. Global Buspirone Price (K Units) by Type (2017-2022)
    Table 38. Global Buspirone Sales (K Units) by Type (2023-2028)
    Table 39. Global Buspirone Sales Share by Type (2023-2028)
    Table 40. Global Buspirone Revenue (US$ Million) Market Share by Type (2023-2028)
    Table 41. Global Buspirone Revenue Share by Type (2023-2028)
    Table 42. Global Buspirone Price (K Units) by Type (2023-2028)
    Table 43. Global Buspirone Sales (K Units) by Application (2017-2022)
    Table 44. Global Buspirone Sales Share by Application (2017-2022)
    Table 45. Global Buspirone Revenue (US$ Million) Market Share by Application (2017-2022)
    Table 46. Global Buspirone Price (K Units) by Application (2017-2022)
    Table 47. Global Buspirone Sales (K Units) by Application (2023-2028)
    Table 48. Global Buspirone Sales Share by Application (2023-2028)
    Table 49. Global Buspirone Revenue (US$ Million) Market Share by Application (2023-2028)
    Table 50. Global Buspirone Revenue Share by Application (2023-2028)
    Table 51. Global Buspirone Price (K Units) by Application (2023-2028)
    Table 52. North America Buspirone Sales by Company (2017-2022) & (K Units)
    Table 53. North America Buspirone Sales Market Share by Company (2017-2022)
    Table 54. North America Buspirone Revenue by Company (2017-2022) & (US$ Million)
    Table 55. North America Buspirone Revenue Market Share by Company (2017-2022)
    Table 56. North America Buspirone Sales by Type (2017-2022) & (K Units)
    Table 57. North America Buspirone Sales by Type (2023-2028) & (K Units)
    Table 58. North America Buspirone Revenue by Type (2017-2022) & (US$ Million)
    Table 59. North America Buspirone Revenue by Type (2023-2028) & (US$ Million)
    Table 60. North America Buspirone Sales by Application (2017-2022) & (K Units)
    Table 61. North America Buspirone Sales by Application (2023-2028) & (K Units)
    Table 62. North America Buspirone Revenue by Application (2017-2022) & (US$ Million)
    Table 63. North America Buspirone Revenue by Application (2023-2028) & (US$ Million)
    Table 64. North America Buspirone Sales by Country (2017-2022) & (K Units)
    Table 65. North America Buspirone Sales by Country (2023-2028) & (K Units)
    Table 66. North America Buspirone Revenue by Country (2017-2022) & (US$ Million)
    Table 67. North America Buspirone Revenue by Country (2023-2028) & (US$ Million)
    Table 68. Europe Buspirone Sales by Company (2017-2022) & (K Units)
    Table 69. Europe Buspirone Sales Market Share by Company (2017-2022)
    Table 70. Europe Buspirone Revenue by Company (2017-2022) & (US$ Million)
    Table 71. Europe Buspirone Revenue Market Share by Company (2017-2022)
    Table 72. Europe Buspirone Sales by Type (2017-2022) & (K Units)
    Table 73. Europe Buspirone Sales by Type (2023-2028) & (K Units)
    Table 74. Europe Buspirone Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Europe Buspirone Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Europe Buspirone Sales by Application (2017-2022) & (K Units)
    Table 77. Europe Buspirone Sales by Application (2023-2028) & (K Units)
    Table 78. Europe Buspirone Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Europe Buspirone Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Europe Buspirone Sales by Country (2017-2022) & (K Units)
    Table 81. Europe Buspirone Sales by Country (2023-2028) & (K Units)
    Table 82. Europe Buspirone Revenue by Country (2017-2022) & (US$ Million)
    Table 83. Europe Buspirone Revenue by Country (2023-2028) & (US$ Million)
    Table 84. Asia Pacific Buspirone Sales by Company (2017-2022) & (K Units)
    Table 85. Asia Pacific Buspirone Sales Market Share by Company (2017-2022)
    Table 86. Asia Pacific Buspirone Revenue by Company (2017-2022) & (US$ Million)
    Table 87. Asia Pacific Buspirone Revenue Market Share by Company (2017-2022)
    Table 88. Asia Pacific Buspirone Sales by Type (2017-2022) & (K Units)
    Table 89. Asia Pacific Buspirone Sales by Type (2023-2028) & (K Units)
    Table 90. Asia Pacific Buspirone Revenue by Type (2017-2022) & (US$ Million)
    Table 91. Asia Pacific Buspirone Revenue by Type (2023-2028) & (US$ Million)
    Table 92. Asia Pacific Buspirone Sales by Application (2017-2022) & (K Units)
    Table 93. Asia Pacific Buspirone Sales by Application (2023-2028) & (K Units)
    Table 94. Asia Pacific Buspirone Revenue by Application (2017-2022) & (US$ Million)
    Table 95. Asia Pacific Buspirone Revenue by Application (2023-2028) & (US$ Million)
    Table 96. Asia Pacific Buspirone Sales by Region (2017-2022) & (K Units)
    Table 97. Asia Pacific Buspirone Sales by Region (2023-2028) & (K Units)
    Table 98. Asia Pacific Buspirone Revenue by Region (2017-2022) & (US$ Million)
    Table 99. Asia Pacific Buspirone Revenue by Region (2023-2028) & (US$ Million)
    Table 100. Latin America Buspirone Sales by Company (2017-2022) & (K Units)
    Table 101. Latin America Buspirone Sales Market Share by Company (2017-2022)
    Table 102. Latin America Buspirone Revenue by Company (2017-2022) & (US$ Million)
    Table 103. Latin America Buspirone Revenue Market Share by Company (2017-2022)
    Table 104. Latin America Buspirone Sales by Type (2017-2022) & (K Units)
    Table 105. Latin America Buspirone Sales by Type (2023-2028) & (K Units)
    Table 106. Latin America Buspirone Revenue by Type (2017-2022) & (US$ Million)
    Table 107. Latin America Buspirone Revenue by Type (2023-2028) & (US$ Million)
    Table 108. Latin America Buspirone Sales by Application (2017-2022) & (K Units)
    Table 109. Latin America Buspirone Sales by Application (2023-2028) & (K Units)
    Table 110. Latin America Buspirone Revenue by Application (2017-2022) & (US$ Million)
    Table 111. Latin America Buspirone Revenue by Application (2023-2028) & (US$ Million)
    Table 112. Latin America Buspirone Sales by Country (2017-2022) & (K Units)
    Table 113. Latin America Buspirone Sales by Country (2023-2028) & (K Units)
    Table 114. Latin America Buspirone Revenue by Country (2017-2022) & (US$ Million)
    Table 115. Latin America Buspirone Revenue by Country (2023-2028) & (US$ Million)
    Table 116. Middle East and Africa Buspirone Sales by Company (2017-2022) & (K Units)
    Table 117. Middle East and Africa Buspirone Sales Market Share by Company (2017-2022)
    Table 118. Middle East and Africa Buspirone Revenue by Company (2017-2022) & (US$ Million)
    Table 119. Middle East and Africa Buspirone Revenue Market Share by Company (2017-2022)
    Table 120. Middle East and Africa Buspirone Sales by Type (2017-2022) & (K Units)
    Table 121. Middle East and Africa Buspirone Sales by Type (2023-2028) & (K Units)
    Table 122. Middle East and Africa Buspirone Revenue by Type (2017-2022) & (US$ Million)
    Table 123. Middle East and Africa Buspirone Revenue by Type (2023-2028) & (US$ Million)
    Table 124. Middle East and Africa Buspirone Sales by Application (2017-2022) & (K Units)
    Table 125. Middle East and Africa Buspirone Sales by Application (2023-2028) & (K Units)
    Table 126. Middle East and Africa Buspirone Revenue by Application (2017-2022) & (US$ Million)
    Table 127. Middle East and Africa Buspirone Revenue by Application (2023-2028) & (US$ Million)
    Table 128. Middle East and Africa Buspirone Sales by Country (2017-2022) & (K Units)
    Table 129. Middle East and Africa Buspirone Sales by Country (2023-2028) & (K Units)
    Table 130. Middle East and Africa Buspirone Revenue by Country (2017-2022) & (US$ Million)
    Table 131. Middle East and Africa Buspirone Revenue by Country (2023-2028) & (US$ Million)
    Table 132. Bristol Myers Squibb Corporation Information
    Table 133. Bristol Myers Squibb Description and Overview
    Table 134. Bristol Myers Squibb Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 135. Bristol Myers Squibb Buspirone Product and Services
    Table 136. Bristol Myers Squibb Buspirone SWOT Analysis
    Table 137. Bristol Myers Squibb Recent Developments
    Table 138. Apotex Corporation Information
    Table 139. Apotex Description and Overview
    Table 140. Apotex Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 141. Apotex Buspirone Product and Services
    Table 142. Apotex Buspirone SWOT Analysis
    Table 143. Apotex Recent Developments
    Table 144. Dr. Reddy's Laboratories Corporation Information
    Table 145. Dr. Reddy's Laboratories Description and Overview
    Table 146. Dr. Reddy's Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 147. Dr. Reddy's Laboratories Buspirone Product and Services
    Table 148. Dr. Reddy's Laboratories Buspirone SWOT Analysis
    Table 149. Dr. Reddy's Laboratories Recent Developments
    Table 150. Laboratoires Servier Corporation Information
    Table 151. Laboratoires Servier Description and Overview
    Table 152. Laboratoires Servier Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 153. Laboratoires Servier Buspirone Product and Services
    Table 154. Laboratoires Servier Buspirone SWOT Analysis
    Table 155. Laboratoires Servier Recent Developments
    Table 156. Teva Corporation Information
    Table 157. Teva Description and Overview
    Table 158. Teva Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 159. Teva Buspirone Product and Services
    Table 160. Teva Buspirone SWOT Analysis
    Table 161. Teva Recent Developments
    Table 162. AMAG Pharmaceuticals Corporation Information
    Table 163. AMAG Pharmaceuticals Description and Overview
    Table 164. AMAG Pharmaceuticals Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 165. AMAG Pharmaceuticals Buspirone Product and Services
    Table 166. AMAG Pharmaceuticals Buspirone SWOT Analysis
    Table 167. AMAG Pharmaceuticals Recent Developments
    Table 168. Mylan Corporation Information
    Table 169. Mylan Description and Overview
    Table 170. Mylan Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 171. Mylan Buspirone Product and Services
    Table 172. Mylan Buspirone SWOT Analysis
    Table 173. Mylan Recent Developments
    Table 174. Novartis Corporation Information
    Table 175. Novartis Description and Overview
    Table 176. Novartis Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 177. Novartis Buspirone Product and Services
    Table 178. Novartis Buspirone SWOT Analysis
    Table 179. Novartis Recent Developments
    Table 180. Watson Laboratories Corporation Information
    Table 181. Watson Laboratories Description and Overview
    Table 182. Watson Laboratories Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 183. Watson Laboratories Buspirone Product and Services
    Table 184. Watson Laboratories Buspirone SWOT Analysis
    Table 185. Watson Laboratories Recent Developments
    Table 186. Hikma Corporation Information
    Table 187. Hikma Description and Overview
    Table 188. Hikma Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 189. Hikma Buspirone Product and Services
    Table 190. Hikma Buspirone SWOT Analysis
    Table 191. Hikma Recent Developments
    Table 192. Wockhardt Corporation Information
    Table 193. Wockhardt Description and Overview
    Table 194. Wockhardt Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 195. Wockhardt Buspirone Product and Services
    Table 196. Wockhardt Recent Developments
    Table 197. Cadila Healthcare Corporation Information
    Table 198. Cadila Healthcare Description and Overview
    Table 199. Cadila Healthcare Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 200. Cadila Healthcare Buspirone Product and Services
    Table 201. Cadila Healthcare Recent Developments
    Table 202. Orion Corporation Corporation Information
    Table 203. Orion Corporation Description and Overview
    Table 204. Orion Corporation Buspirone Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
    Table 205. Orion Corporation Buspirone Product and Services
    Table 206. Orion Corporation Recent Developments
    Table 207. Key Raw Materials Lists
    Table 208. Raw Materials Key Suppliers Lists
    Table 209. Buspirone Distributors List
    Table 210. Buspirone Customers List
    Table 211. Research Programs/Design for This Report
    Table 212. Key Data Information from Secondary Sources
    Table 213. Key Data Information from Primary Sources
List of Figures
    Figure 1. Buspirone Product Picture
    Figure 2. Global Buspirone Sales Market Share by Type in 2021 & 2028
    Figure 3. 5mg Product Picture
    Figure 4. 10mg Product Picture
    Figure 5. 15mg Product Picture
    Figure 6. 30mg Product Picture
    Figure 7. Global Buspirone Sales Market Share by Application in 2021 & 2028
    Figure 8. Hospital Use Case
    Figure 9. Drug Store Use Case
    Figure 10. Buspirone Report Years Considered
    Figure 11. Global Buspirone Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Buspirone Market Size 2017-2028 (US$ Million)
    Figure 13. Global Buspirone Sales (2017-2022) & (K Units)
    Figure 14. Global Buspirone Market Size Market Share by Region: 2021 VS 2028
    Figure 15. Global Buspirone Sales Market Share by Region (2017-2022)
    Figure 16. Global Buspirone Sales Market Share by Region in 2021
    Figure 17. Global Buspirone Revenue Market Share by Region in 2017 VS 2021
    Figure 18. Global Buspirone Sales Share by Manufacturers in 2021
    Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Buspirone Sales in 2021
    Figure 20. Buspirone Revenue Share by Manufacturers in 2021
    Figure 21. Buspirone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 22. Global Buspirone Revenue Share by Type (2017-2022)
    Figure 23. Global Buspirone Revenue Growth Rate by Type in 2017 & 2021
    Figure 24. Global Buspirone Revenue Share by Application (2017-2022)
    Figure 25. Global Buspirone Revenue Growth Rate by Application in 2017 & 2021
    Figure 26. North America Buspirone Sales Market Share by Type (2017-2028)
    Figure 27. North America Buspirone Revenue Market Share by Type (2017-2028)
    Figure 28. North America Buspirone Sales Market Share by Application (2017-2028)
    Figure 29. North America Buspirone Revenue Market Share by Application (2017-2028)
    Figure 30. North America Buspirone Sales Share by Country (2017-2028)
    Figure 31. North America Buspirone Revenue Share by Country (2017-2028)
    Figure 32. United States Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 33. Canada Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 34. Europe Buspirone Sales Market Share by Type (2017-2028)
    Figure 35. Europe Buspirone Revenue Market Share by Type (2017-2028)
    Figure 36. Europe Buspirone Sales Market Share by Application (2017-2028)
    Figure 37. Europe Buspirone Revenue Market Share by Application (2017-2028)
    Figure 38. Europe Buspirone Sales Share by Country (2017-2028)
    Figure 39. Europe Buspirone Revenue Share by Country (2017-2028)
    Figure 40. Germany Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 41. France Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 42. U.K. Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 43. Italy Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 44. Russia Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 45. Asia Pacific Buspirone Sales Market Share by Type (2017-2028)
    Figure 46. Asia Pacific Buspirone Revenue Market Share by Type (2017-2028)
    Figure 47. Asia Pacific Buspirone Sales Market Share by Application (2017-2028)
    Figure 48. Asia Pacific Buspirone Revenue Market Share by Application (2017-2028)
    Figure 49. Asia Pacific Buspirone Sales Share by Region (2017-2028)
    Figure 50. Asia Pacific Buspirone Revenue Share by Region (2017-2028)
    Figure 51. China Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 52. Japan Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 53. South Korea Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 54. India Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 55. Australia Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 56. China Taiwan Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 57. Indonesia Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 58. Thailand Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 59. Malaysia Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 60. Latin America Buspirone Sales Market Share by Type (2017-2028)
    Figure 61. Latin America Buspirone Revenue Market Share by Type (2017-2028)
    Figure 62. Latin America Buspirone Sales Market Share by Application (2017-2028)
    Figure 63. Latin America Buspirone Revenue Market Share by Application (2017-2028)
    Figure 64. Latin America Buspirone Sales Share by Country (2017-2028)
    Figure 65. Latin America Buspirone Revenue Share by Country (2017-2028)
    Figure 66. Mexico Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 67. Brazil Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 68. Argentina Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 69. Middle East and Africa Buspirone Sales Market Share by Type (2017-2028)
    Figure 70. Middle East and Africa Buspirone Revenue Market Share by Type (2017-2028)
    Figure 71. Middle East and Africa Buspirone Sales Market Share by Application (2017-2028)
    Figure 72. Middle East and Africa Buspirone Revenue Market Share by Application (2017-2028)
    Figure 73. Middle East and Africa Buspirone Sales Share by Country (2017-2028)
    Figure 74. Middle East and Africa Buspirone Revenue Share by Country (2017-2028)
    Figure 75. Turkey Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 76. Saudi Arabia Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 77. UAE Buspirone Revenue (2017-2028) & (US$ Million)
    Figure 78. Buspirone Value Chain
    Figure 79. Buspirone Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5600

This license allows only one user to access the PDF.
Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions